Biotech | August 05, 2021
Biotech-PRIDE guidelines released
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
It works as an adjunct to standard care based on robust clinical trials
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
India business is growing as per projections; whereas US business will bounce back soon.
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
Q1 FY22 consolidated revenue grew 6% to Rs. 1,808 crore from Rs. 1,712 crore in Q1 FY21. Q1 FY22 Net Profit was Rs. 84 crore (vs. Rs. 149 crore in Q1 FY21).
Subscribe To Our Newsletter & Stay Updated
